These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14656119)

  • 1. Synthesis of macrocyclic peptide analogues of proteasome inhibitor TMC-95A.
    Berthelot A; Piguel S; Le Dour G; Vidal J
    J Org Chem; 2003 Dec; 68(25):9835-8. PubMed ID: 14656119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A convergent synthesis of the fully elaborated macrocyclic core of TMC-95A.
    Coste A; Bayle A; Marrot J; Evano G
    Org Lett; 2014 Mar; 16(5):1306-9. PubMed ID: 24559256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMC-95A analogues with endocyclic biphenyl ether group as proteasome inhibitors.
    Kaiser M; Milbradt AG; Siciliano C; Assfalg-Machleidt I; Machleidt W; Groll M; Renner C; Moroder L
    Chem Biodivers; 2004 Jan; 1(1):161-73. PubMed ID: 17191784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A concise formal total synthesis of TMC-95A/B proteasome inhibitors.
    Albrecht BK; Williams RM
    Org Lett; 2003 Jan; 5(2):197-200. PubMed ID: 12529139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide macrocyclization: the reductase of the nostocyclopeptide synthetase triggers the self-assembly of a macrocyclic imine.
    Kopp F; Mahlert C; Grünewald J; Marahiel MA
    J Am Chem Soc; 2006 Dec; 128(51):16478-9. PubMed ID: 17177378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A concise, total synthesis of the TMC-95A/B proteasome inhibitors.
    Albrecht BK; Williams RM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11949-54. PubMed ID: 15163792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear TMC-95-based proteasome inhibitors.
    Basse N; Piguel S; Papapostolou D; Ferrier-Berthelot A; Richy N; Pagano M; Sarthou P; Sobczak-Thépot J; Reboud-Ravaux M; Vidal J
    J Med Chem; 2007 Jun; 50(12):2842-50. PubMed ID: 17511440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome.
    Groll M; Götz M; Kaiser M; Weyher E; Moroder L
    Chem Biol; 2006 Jun; 13(6):607-14. PubMed ID: 16793518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumyl ester as the C-terminal protecting group in the enantioselective alkylation of glycine benzophenone imine.
    Respondek T; Cueny E; Kodanko JJ
    Org Lett; 2012 Jan; 14(1):150-3. PubMed ID: 22149572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological characterization of argyrin F.
    Bülow L; Nickeleit I; Girbig AK; Brodmann T; Rentsch A; Eggert U; Sasse F; Steinmetz H; Frank R; Carlomagno T; Malek NP; Kalesse M
    ChemMedChem; 2010 Jun; 5(6):832-6. PubMed ID: 20358576
    [No Abstract]   [Full Text] [Related]  

  • 11. Enantioselective synthesis of non-natural aromatic alpha-amino acids.
    Krebs A; Ludwig V; Pfizer J; Dürner G; Göbel MW
    Chemistry; 2004 Jan; 10(2):544-53. PubMed ID: 14735523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic asymmetric synthesis of the central tryptophan residue of celogentin C.
    Castle SL; Srikanth GS
    Org Lett; 2003 Oct; 5(20):3611-4. PubMed ID: 14507185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding mode of TMC-95A analogues to eukaryotic 20S proteasome.
    Kaiser M; Groll M; Siciliano C; Assfalg-Machleidt I; Weyher E; Kohno J; Milbradt AG; Renner C; Huber R; Moroder L
    Chembiochem; 2004 Sep; 5(9):1256-66. PubMed ID: 15368577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis of anti-HIV agent chloropeptin I.
    Deng H; Jung JK; Liu T; Kuntz KW; Snapper ML; Hoveyda AH
    J Am Chem Soc; 2003 Jul; 125(30):9032-4. PubMed ID: 15369357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereocontrolled synthesis of the northern part of potent proteasome inhibitor TMC-95A.
    Inoue M; Furuyama H; Sakazaki H; Hirama M
    Org Lett; 2001 Sep; 3(18):2863-5. PubMed ID: 11529776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinyl ester-based cyclic peptide proteasome inhibitors.
    Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending Pummerer reaction chemistry. Application to the oxidative cyclization of tryptophan derivatives.
    Feldman KS; Karatjas AG
    Org Lett; 2004 Aug; 6(17):2849-52. PubMed ID: 15330630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of methodology for the synthesis of cyclic thioether peptide libraries derived from linear tripeptides.
    Roberts KD; Ede NJ
    J Pept Sci; 2007 Dec; 13(12):811-21. PubMed ID: 17880033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly convergent and efficient synthesis of a macrocyclic hepatitis C virus protease inhibitor BI 201302.
    Wei X; Shu C; Haddad N; Zeng X; Patel ND; Tan Z; Liu J; Lee H; Shen S; Campbell S; Varsolona RJ; Busacca CA; Hossain A; Yee NK; Senanayake CH
    Org Lett; 2013 Mar; 15(5):1016-9. PubMed ID: 23406520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical enantioselective synthesis of odanacatib, a potent Cathepsin K inhibitor, via triflate displacement of an alpha-trifluoromethylbenzyl triflate.
    O'Shea PD; Chen CY; Gauvreau D; Gosselin F; Hughes G; Nadeau C; Volante RP
    J Org Chem; 2009 Feb; 74(4):1605-10. PubMed ID: 19140725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.